Ask AI
Novel Schizophrenia Treatments

CE / CME

Strategic Steps in Schizophrenia: Mastering Modern Muscarinic Management

Psychologists: 0.50 APA CE Credit

Social Workers: 0.50 ASWB ACE CE Credit

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Pharmacists: 0.50 contact hour (0.05 CEUs)

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: July 24, 2025

Expiration: July 23, 2026

Activity

Progress
1 2
Course Completed

Andrew has stabilized on xanomeline/trospium with significant improvement in psychotic symptoms, clarity of thinking, and overall functionality. Throughout treatment initiation and early maintenance, lorazepam was used to manage insomnia and anxiety, significantly enhancing his comfort and adherence. Andrew is now questioning whether lorazepam should be continued indefinitely alongside his stable xanomeline/trospium regimen.

Given Andrew’s current stability and effective use of lorazepam for symptomatic management, what is the optimal strategy regarding the continued use of lorazepam?